Brief: Algorae Pharmaceuticals Provides NTCELL Project Update

Algorae Pharmaceuticals

14/02/2024 10:27

Feb 14 (Reuters) - Algorae Pharmaceuticals Ltd  1AI.AX :
    * NTCELL PROJECT UPDATE
    * CONTINUES ITS SCIENTIFIC REVIEW OF NTCELL DEVELOPMENT
PROGRAM
    * RESOLVED TO TERMINATE ITS AGREEMENT WITH NZENO LTD WITH
IMMEDIATE EFFECT
    * INVESTIGATING UTILITY OF THERAPEUTIC APPROACH THAT
COMBINES DEEP
BRAIN STIMULATION AND NTCELL IMPLANTED THERAPY
    * CO AND NZENO RESOLVED TO ENTER NEW DISCUSSIONS FOR
PROVISION OF
CHOROID PLEXUS TISSUE IN FUTURE

Source text for Eikon:  ID:nASX8LjlnC 
Further company coverage:  1AI.AX 

 ((Reuters.Briefs@thomsonreuters.com;))